Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Gift | $17,776 | 5 | 95.2% |
| Food and Beverage | $903.69 | 55 | 4.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| USWM, LLC | $9,547 | 5 | $0 (2021) |
| US WorldMeds, LLC | $8,272 | 3 | $0 (2020) |
| Indivior Inc. | $143.95 | 8 | $0 (2019) |
| Boston Scientific Corporation | $138.46 | 2 | $0 (2018) |
| Medtronic USA, Inc. | $67.93 | 4 | $0 (2017) |
| Pernix Therapeutics Holdings, Inc. | $62.80 | 4 | $0 (2017) |
| BioDelivery Sciences International, Inc. | $52.00 | 4 | $0 (2021) |
| Daiichi Sankyo Inc. | $48.44 | 4 | $0 (2018) |
| Purdue Pharma L.P. | $47.54 | 4 | $0 (2017) |
| GRT US Holding, Inc. | $36.45 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $9,657 | 12 | USWM, LLC ($9,547) |
| 2020 | $8,261 | 2 | US WorldMeds, LLC ($8,261) |
| 2019 | $53.48 | 3 | Indivior Inc. ($25.09) |
| 2018 | $278.99 | 11 | Boston Scientific Corporation ($121.76) |
| 2017 | $430.04 | 32 | Medtronic USA, Inc. ($67.93) |
All Payment Transactions
60 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/29/2021 | USWM, LLC | Lucemyra (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/27/2021 | Bioventus LLC | Stimrouter Implantable Kit (Device) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Podiatry | ||||||
| 08/19/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: Chronic Pain | ||||||
| 08/12/2021 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Pain Management | ||||||
| 07/24/2021 | USWM, LLC | Lucemyra (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: Psychiatry/Psychology | ||||||
| 06/29/2021 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Pain Management | ||||||
| 06/29/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: Chronic Pain | ||||||
| 04/27/2021 | USWM, LLC | Lucemyra (Drug) | Gift | In-kind items and services | $4,704.48 | General |
| Category: Psychiatry/Psychology | ||||||
| 04/27/2021 | USWM, LLC | Lucemyra (Drug) | Gift | In-kind items and services | $4,094.40 | General |
| Category: Psychiatry/Psychology | ||||||
| 03/24/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Gastroenterology | ||||||
| 03/18/2021 | USWM, LLC | Lucemyra (Drug) | Gift | In-kind items and services | $716.52 | General |
| Category: Psychiatry/Psychology | ||||||
| 03/09/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Chronic Pain | ||||||
| 12/21/2020 | US WorldMeds, LLC | Lucemyra (Drug) | Gift | In-kind items and services | $4,155.48 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/21/2020 | US WorldMeds, LLC | Lucemyra (Drug) | Gift | In-kind items and services | $4,105.08 | General |
| Category: Psychiatry/Psychology | ||||||
| 07/08/2019 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $11.04 | General |
| Category: Addiction Medicine | ||||||
| 03/28/2019 | Titan Pharmaceuticals, Inc. | Probuphine (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Maintenance Treatment of Opioid Dependence | ||||||
| 01/28/2019 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: OUD | ||||||
| 11/26/2018 | US WorldMeds, LLC | Lucemyra/Lofexidine (Drug) | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/15/2018 | Indivior Inc. | SUBLOCADE (Drug), SUBOXONE SUBLINGUAL FILM | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: OUD | ||||||
| 08/27/2018 | Indivior Inc. | SUBLOCADE (Drug), SUBOXONE SUBLINGUAL FILM | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: OUD | ||||||
| 07/25/2018 | Indivior Inc. | SUBLOCADE (Drug), SUBOXONE SUBLINGUAL FILM | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: OUD | ||||||
| 04/25/2018 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $13.58 | General |
| Category: AED | ||||||
| 03/13/2018 | Indivior Inc. | SUBLOCADE (Drug), SUBOXONE SUBLINGUAL FILM | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: OUD | ||||||
| 03/05/2018 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 02/28/2018 | Boston Scientific Corporation | SPECTRA WAVEWRITER (Device) | Food and Beverage | In-kind items and services | $121.76 | General |
| Category: PAIN MANAGEMENT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 13 | 514 | 1,562 | $262,535 | $109,789 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 140 | 568 | $139,160 | $54,979 | 39.5% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 159 | 582 | $74,184 | $36,165 | 48.8% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 30 | 31 | $15,314 | $7,433 | 48.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 25 | 28 | $9,604 | $3,846 | 40.0% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 14 | 14 | $4,760 | $2,782 | 58.5% |
| 99152 | Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes | Office | 2021 | 25 | 50 | $7,500 | $1,848 | 24.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $3,498 | $1,401 | 40.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 13 | $1,560 | $895.96 | 57.4% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2021 | 15 | 37 | $370.00 | $190.81 | 51.6% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2021 | 11 | 22 | $572.00 | $101.22 | 17.7% |
| J3490 | Unclassified drugs | Office | 2021 | 23 | 51 | $3,300 | $82.50 | 2.5% |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 2021 | 25 | 50 | $2,500 | $55.40 | 2.2% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2021 | 23 | 105 | $212.80 | $9.60 | 4.5% |
About Dr. Michael Fletcher, MD
Dr. Michael Fletcher, MD is a Addiction Medicine healthcare provider based in Florence, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063476216.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Fletcher, MD has received a total of $18,680 in payments from pharmaceutical and medical device companies, with $9,657 received in 2021. These payments were reported across 60 transactions from 25 companies. The most common payment nature is "Gift" ($17,776).
As a Medicare-enrolled provider, Fletcher has provided services to 514 Medicare beneficiaries, totaling 1,562 services with total Medicare billing of $109,789. Data is available for 1 year (2021–2021), covering 13 distinct procedure/service records.
Practice Information
- Specialty Addiction Medicine
- Other Specialties Addiction Medicine, Addiction Medicine
- Location Florence, KY
- Active Since 04/14/2006
- Last Updated 02/07/2022
- Taxonomy Code 207LA0401X
- Entity Type Individual
- NPI Number 1063476216
Products in Payments
- Lucemyra (Drug) $17,807
- SPECTRA WAVEWRITER (Device) $121.76
- SUBLOCADE (Drug) $106.20
- ADAPTIVESTIM (Device) $67.93
- ZOHYDRO ER (Drug) $49.28
- BELBUCA (Drug) $40.49
- SUBOXONE SUBLINGUAL FILM (Drug) $37.75
- Qutenza (Drug) $36.45
- Movantik (Drug) $34.44
- Probuphine (Drug) $34.06
- Evzio (Drug) $26.12
- OXYCONTIN (Drug) $25.70
- LYRICA (Drug) $24.94
- Zubsolv (Drug) $24.71
- BOTOX-NEUROLOGY (Drug) $23.79
- SPRIX (Drug) $21.92
- Stimrouter Implantable Kit (Device) $18.38
- GENERAL - PAIN MANAGEMENT (Device) $16.70
- Xtampza ER (Drug) $14.94
- RELISTOR (Drug) $14.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.